We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

A Novel Non-Amplification Assay Detects Leishmania

By LabMedica International staff writers
Posted on 10 Mar 2014
Print article
Image: the Infinite M200 spectrophotometer (Photo courtesy of Tecan).
Image: the Infinite M200 spectrophotometer (Photo courtesy of Tecan).
The need for accurate diagnostic investigation of cases of leishmaniasis has made the use of molecular biology techniques broadly applicable for identifying the protozoan parasite.

The reliable application of these methods requires highly specialized personnel, dedicated equipment and space and because of these drawbacks of the molecular diagnostic approach, has targeted several alternatives and the most recent of which is the incorporation of nanoparticles for the detection of specific bio-molecules.

Laboratory scientists at the University of Athens (Greece) used for the assessment of the method’s specificity 15 cultured isolates of various Leishmania species from human and animal origin. There were 40 negative controls selected among pathogens genetically related to Leishmania spp., commonly found in clinical samples, both human and canine, as well as some bacterial species.

DNA isolation was performed on all samples by the Nucleospin Tissue kit (Macherey Nagel; Düren, Germany). Gold nanoparticles (AuNPs, Nanopartz; Salt Lake City, UT, USA) were conjugated with four oligonucleotide probes, targeting kinetoplastid minicircle DNA of Leishmania spp. The results were recorded by visual observation of the test tubes or by spectrophotometry (Infinite M200, Tecan; Männedorf Switzerland). In the absence of complimentary DNA, AuNPs-probes precipitate under acid environment causing a change of color from red to purple, which can be detected by visual observation. In the presence of target DNA the color of the solution remains red.

The assay produced consistently positive results detectable by simple visual observation of the test tubes with no less than 115 ng of leishmanial DNA in a sample volume of 10 μL and therefore the method's minimum detection limit was defined as 11.5 ng of target DNA per μL of sample. Repeatability and reproducibility were 100% and relative sensitivity and specificity referenced to a classical polymerase chain reaction (PCR) method were calculated to 92% and 100% regarding collectively control and clinical samples.

The authors concluded that the method provides an easy, fast, and inexpensive way for Leishmania DNA detection using AuNPs conjugated to four single strand oligonucleotide-probes. This approach can be considered an appealing diagnostic solution for resource-poor settings, especially for screening purposes in enzootic areas, where detection of very small amounts of the targeted analyte is not a top priority. The study was published in the January 2014 issue of the Journal of Microbiological Methods.

Related Links:

University of Athens
Macherey Nagel
Tecan


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more